(Q28274039)

Crossref

https://api.crossref.org/works/10.1007%2FBF02367786

Enprostil and ranitidine: comparative efficacy and safety in patients with duodenal ulcer

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02367786

Incidence of Gastric Lesions in Patients with Rheumatic Disease on Chronic Aspirin Therapy

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02367786

Misoprostol, a synthetic prostaglandin E1 analogue, in the treatment of duodenal ulcers. A double-blind, cimetidine-controlled trial

21 January 2018

1 reference

12 December 2020

Enprostil and cimetidine: comparative efficacy and safety in patients with duodenal ulcer

1 reference

12 December 2020

A comparative study of misoprostol and ranitidine in the healing of duodenal ulcers. A double-blind controlled trial

1 reference

12 December 2020

The prevalence of duodenal lesions in patients with rheumatic diseases on chronic aspirin therapy

1 reference

12 December 2020

Nonsteroidal anti-inflammatory drug-associated gastropathy: incidence and risk factor models

1 reference

12 December 2020

Duodenal and gastric ulcer prevention with misoprostol in arthritis patients taking NSAIDs. Misoprostol Study Group

1 reference

12 December 2020

Prevention of NSAID-induced gastric ulcer with misoprostol: multicentre, double-blind, placebo-controlled trial

1 reference

12 December 2020

Clinical spectrum of the upper gastrointestinal effects of nonsteroidal anti-inflammatory drugs. Natural history, symptomatology, and significance

1 reference

12 December 2020

Misoprostol in the treatment of duodenal ulcer refractory to H2-blocker therapy. A placebo-controlled, multicenter, double-blind, randomized trial.

1 reference

12 December 2020

Efficacy and tolerability of enprostil in the treatment of duodenal ulcer. Comparison with cimetidine

1 reference

12 December 2020

Comparison of enprostil and cimetidine in active duodenal ulcer disease. Summary of pooled European studies

1 reference

12 December 2020

Prostaglandin E1 (Misoprostol) overcomes the adverse effect of chronic cigarette smoking on duodenal ulcer healing

1 reference

12 December 2020

A report of three multiclinic trials evaluating arbaprostil in arthritic patients with ASA/NSAID gastric mucosal damage. The Upjohn Company Arbaprostil ASA/NSAID Gastric Mucosal Damage Treatment Study Groups

1 reference

12 December 2020

Duodenal ulcer therapy with low-dose antacids: a multicenter trial.

1 reference

12 December 2020

Enprostil, a prostaglandin E2 analogue, in the treatment of duodenal ulcer; a multicentre comparison with cimetidine

1 reference

12 December 2020

Microscopic analysis of ethanol damage to rat gastric mucosa after treatment with a prostaglandin.

1 reference

12 December 2020

Treatment of duodenal ulcer with enprostil, a prostaglandin E2 analogue

1 reference

12 December 2020

A comparison of enprostil and ranitidine in treatment of duodenal ulcer

1 reference

12 December 2020

Peptic ulcer in rheumatoid arthritis

1 reference

12 December 2020

Gastroscopic evaluation of anti-inflammatory agents

1 reference

12 December 2020

A US multicenter study of enprostil 35 micrograms twice daily for treatment of prepyloric, pyloric channel, and duodenal bulb ulcers. Enprostil Study Group

1 reference

12 December 2020

Treatment of gastric ulcer with enprostil

1 reference

12 December 2020

Misoprostol, a synthetic PGE1 analog, in the treatment of duodenal ulcers. A multicenter double-blind study

1 reference

12 December 2020

Misoprostol in the treatment of duodenal ulcer. A multicenter double-blind placebo-controlled study

1 reference

12 December 2020

Enprostil and ranitidine in duodenal ulcer healing: double blind comparative trial.

1 reference

12 December 2020

Humanitarian use of misoprostol in severe refractory upper gastrointestinal disease

1 reference

12 December 2020

A double-blind study of misoprostol (SC-29333) in the healing of duodenal ulcer

1 reference

12 December 2020

Prophylactic and therapeutic role of rioprostil in NSAIDs induced gastroduodenal lesions

1 reference

12 December 2020

A multicenter international controlled comparison of two dosage regimes of misoprostol and cimetidine in the treatment of duodenal ulcer in out-patients

1 reference

12 December 2020

Comparison of misoprostol and ranitidine in the treatment of duodenal ulcer.

1 reference

12 December 2020

Dyspepsia in NSAID users: the size of the problem

1 reference

12 December 2020

Dose-response, meal-stimulated gastric antisecretory study of prostaglandin E1 analog, misoprostol, in man.

1 reference

12 December 2020

Antisecretory and mucosal protective actions of misoprostol. Potential role in the treatment of peptic ulcer disease

1 reference

12 December 2020

Enprostil. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of peptic ulcer disease

1 reference

12 December 2020

A comparison of low-dose maintenance treatment with enprostil against ranitidine in the prevention of duodenal ulcer recurrence

1 reference

12 December 2020

Twenty-four-hour intragastric acidity and clinical trial of bedtime enprostil 70 micrograms compared with ranitidine 300 mg in duodenal ulcer

1 reference

12 December 2020

Enprostil and ranitidine in prevention of duodenal ulcer relapse: one year double blind comparative trial.

1 reference

12 December 2020

Misoprostol for the treatment of peptic ulcer and antiinflammatory-drug-induced gastroduodenal ulceration

1 reference

12 December 2020

Misoprostol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of peptic ulcer disease

1 reference

12 December 2020

Treatment of duodenal ulcer with enprostil, a synthetic prostaglandin E2 analogue

1 reference

12 December 2020

Efficacy of misoprostol (twice daily dosage) in acute healing of duodenal ulcer. A multicenter double-blind controlled trial

1 reference

12 December 2020

Inhibition of nocturnal gastric secretion in normal human volunteers by misoprostol: a synthetic prostaglandin E1 methyl ester analog

1 reference

12 December 2020